PDCD1 and neoplasm: Since the PD-L1/CD274 expression of antigen-presenting cells might lead to an inhibition of antitumor responses following the presentation of tumor antigens to T cells, the aim of this study was to evaluate PD-L1/CD274 expression of blood monocytes and DC subpopulations in lung cancer patients undergoing PD1 inhibitor therapy with respect to their effect on therapy response and prognosis.